1. Home
  2. INVH vs SPRC Comparison

INVH vs SPRC Comparison

Compare INVH & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invitation Homes Inc.

INVH

Invitation Homes Inc.

HOLD

Current Price

$27.45

Market Cap

16.5B

Sector

Finance

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$1.48

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVH
SPRC
Founded
2012
2004
Country
United States
Israel
Employees
N/A
2
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
4.8M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
INVH
SPRC
Price
$27.45
$1.48
Analyst Decision
Buy
Analyst Count
15
0
Target Price
$34.90
N/A
AVG Volume (30 Days)
5.3M
1.3M
Earning Date
10-29-2025
03-23-2026
Dividend Yield
4.37%
N/A
EPS Growth
32.35
N/A
EPS
0.95
N/A
Revenue
$2,689,621,000.00
$1,306,000.00
Revenue This Year
$5.69
N/A
Revenue Next Year
$3.21
N/A
P/E Ratio
$28.89
N/A
Revenue Growth
5.29
187.98
52 Week Low
$26.02
$1.30
52 Week High
$35.80
$37.59

Technical Indicators

Market Signals
Indicator
INVH
SPRC
Relative Strength Index (RSI) 50.57 34.70
Support Level $26.72 $1.35
Resistance Level $27.43 $1.71
Average True Range (ATR) 0.47 0.17
MACD 0.10 0.02
Stochastic Oscillator 93.29 21.88

Price Performance

Historical Comparison
INVH
SPRC

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: